(Q43741128)

26 November 2017

title

Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation (English)

1 reference

26 November 2017

0 references

6

van Rhee F

1 reference

26 November 2017

Chiang KY

1

1 reference

26 November 2017

Hazlett LJ

2

1 reference

26 November 2017

Godder KT

3

1 reference

26 November 2017

Abhyankar SH

4

1 reference

26 November 2017

Christiansen NP

5

1 reference

26 November 2017

Lee CG

7

1 reference

26 November 2017

Bridges K

8

1 reference

26 November 2017

Parrish RS

9

1 reference

26 November 2017

Henslee-Downey PJ

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bone Marrow Transplantation

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

12

1 reference

26 November 2017

page(s)

1117-1123

1 reference

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: An initial report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703311

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1703311

1 reference

Dimensions Publication ID

26 November 2017

1041589993

0 references

1 reference